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Objectives: To assess whether the cutaneous features in patients with dengue fever are
associated with abnormal blood biochemistry, complications, and poor disease outcome.
Methods: Forty ﬁve patients with dengue fever were identiﬁed at a medical center in
Kaohsiung, Taiwan, from September to November 2014. All cases were exclusively
caused by type 1 dengue virus. Patients were classiﬁed into two groups, based on the
presence or absence of skin rash, and their rash was subclassiﬁed into maculopapular,
morbilliform, and petechial types. Clinical symptoms, laboratory data, disease outcome,
and complications were compared between the two groups.
Results: Thirty two patients with dengue fever developed skin rash (SP group, n = 32)
while the rest of 13 did not (SN group, n = 13). The patient numbers in the mac-
ulopapular, morbilliform, and petechial group were 4, 21, and 7, respectively. The SP
group was younger (P = 0.001), experienced more pruritus (P = 0.008) and more swollen
palms/soles (P = 0.015) than the SN group. However, the SN group had greater genital
mucosa involvement (P = 0.008), higher platelet transfusion rate (P = 0.003), and lower
hemoglobin and hematocrit levels (P = 0.030) than the SP group. Patients with morbil-
liform lesions had a higher incidence of palm/sole swelling, less genital mucosal
involvement, and a lower platelet transfusion rate than did patients with maculopapular or
petechial lesions.
Conclusions: Cutaneous manifestations provide an important clue to dengue fever. In
patients with dengue fever, those with skin rash tend to have itching and swelling of the
palms/soles, however, those without skin rash tend to have more complications and poor
disease outcomes.1. Introduction
Dengue fever (DF) is caused by the dengue virus (DENV), a
single-strand RNA ﬂavivirus of the family Flaviviridae, a family
that also includes the West Nile and yellow fever viruses. The
viral etiology of DF has been established since the 1940s [1], and
the history of dengue-like diseases can be traced back more than
200 years. The mosquito Aedes aegypti is the major vector and
the true reservoir for the virus [2].The incidence of DF has signiﬁcantly surged in recent years,
especially in southern Taiwan during the summer. Globally,
approximately 2.5 billion people are estimated to live in
dengue-endemic regions, and 50 to 100 million people are
infected by dengue virus annually [3]. According to Taiwan
Center for Disease Control (CDC), approximately 1000 to
2000 people are infected by dengue virus annually [4]. In
2014, Taiwan experienced its large dengue virus outbreak,
with the numbers of patients reached record high (>10000)
since 1981 [5].
The typical clinical manifestations of DF vary from self-
limited DF to severe dengue hemorrhagic fever and fatal
dengue shock syndrome. Most DENV infections are asymp-
tomatic [3]. The classical presentation of mild form of DF
includes fever, headache, retro-orbital pain, varied skin rash,
myalgia, and arthralgias. In contrast, the severe forms of DF,rticle under the CC BY-NC-ND license (http://
Table 1
Demographic data, clinical symptoms, and outcome of DENV infection
patients.
Parameters SP group
(n = 32)
SN group
(n = 13)
P
Age (year) 48.46 63.69 0.001*
Males (n, %) 14 (43.75) 5 (38.46) 0.376
Females (n, %) 18 (56.25) 8 (61.54) 0.376
Associated symptoms
Rash onset after fever (d) 3.91 0 X
Fever duration
(d, mean ± SD)
4.52 ± 2.46 2.31 ± 1.90 0.177
Itch (VAS = 1–10,
mean ± SD)
2.06 ± 2.26 0.28 ± 1.39 0.008*
Palm/sole
swelling (n, %)
13 (40.63) 1 (7.69) 0.015*
Mucosal involvement
Oral (n, %) 4 (12.50) 0 (0) 0.095
Eye (n, %) 1 (3.12) 0 (0) 0.265
Genital (n, %) 10 (31.25) 8 (61.54) 0.008*
Gastrointestinal (n, %) 3 (9.38) 2 (15.38) 0.306
Dengue hemorrhagic
fever (n, %)
4 (12.5) 2 (15.4) 0.406
Hemorrhagic
manifestation (n, %)**
14 (43.75) 9 (69.23) 0.063
Platelet transfusion (n, %) 1 (3.16) 4 (30.77) 0.003*
Hospitalization days
(d, mean ± SD)
6.48 ± 2.47 7.85 ± 3.87 0.15
Disease course
(d, mean ± SD)
9.63 ± 3.62 10.62 ± 3.20 0.25
*A two-tailed P < 0.05 was considered statistically signiﬁcant. **Stool
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drome, are accompanied by thrombocytopenia, and often are
fatal.
Previous studies recorded that cutaneous manifestations are
present in 65% of patients [6]. A generalized morbilliform rash or
a conﬂuent erythematous rash with white islands of sparing
petechiae is common [6]. Skin lesions may be the ﬁrst
symptom of DF, and can be helpful for making the diagnosis.
However, very few studies have examined the clinical
implications, including complications and disease outcomes, of
skin rash in patients with DENV infections. In this study, we
attempt to compare the differences in laboratory data, disease
course, associated symptoms, and treatment prognosis among
DF patients with and without skin rash.
2. Materials and methods
2.1. Study population
The prospective study was conducted by the Department of
Dermatology at Kaohsiung Chang Gung Memorial Hospital,
Kaohsiung, Taiwan, from September to November 2014. The
hospital is a medical facility with 2700 beds that serves as a
tertiary referral center in southern Taiwan.
Forty ﬁve adult patients 18 years of age or older were
enrolled in the study. All patients included in the study had been
admitted to the hospital via the hospital's emergency department,
and had DENV infection conﬁrmed by laboratory studies. The
45 patients were subsequently divided into 2 groups: (1) those
who developed a skin rash (SP group; n = 32) and those who did
not (SN; n = 13). Clinical examination to assess the various
cutaneous features was carried out and the relevant in-
vestigations, including a battery of serology tests, were done.
2.2. Study criteria
All dengue cases included in this study were conﬁrmed by
one of the following criteria: (1) a positive DENV-speciﬁc real-
time reverse transcription polymerase chain reaction (RT-PCR;
QuantiTect SYBR® Green RT-PCR Kit; QIAGEN GmbH,
Hilden, Germany); or (2) acute-phase serum positive for DENV-
speciﬁc non-structural glycoprotein-1 antigen (Bio-Rad Labo-
ratories, Inc, Marnes-la-Coquette, France). These diagnostic
tests were performed by Taiwan CDC.
A visual analogue scale (VAS) was used as a subjective
evaluation tool to evaluate the degree of pruritus [7]. A VAS is
one of the most commonly used methods of assessing the
severity of pruritus, and it provides an easy and rapid
estimation of itching. Based on detailed analysis from the
VAS scores, the extent of pruritus was categorized as: 0,
indicating no pruritus, while a VAS score of 10 indicated very
severe pruritus. Patients were excluded if they lost follow up
and didn't have complete medical records in this hospital.
2.3. Data analysis
SPSS software (Version 17; SPSS, Chicago, IL, USA) was
used for statistical analyses. Mean values and standard de-
viations were performed for all groups. We performed the un-
paired Student's t-test to evaluate the clinical symptoms,
laboratory features, disease outcomes, and complicationsbetween the skin rash group (SP group) and control group (SN
group). Analysis of variance (ANOVA) and post-hoc analysis
were done to evaluate the clinical symptoms, complications and
disease outcomes concerning all group differences, and subse-
quently for further group–group differences between different
skin rash types. Signiﬁcance was deﬁned as a P-value <0.05,
with a two-tailed test.
3. Results
3.1. Demographic data, clinical symptoms, and disease
outcome in SP and SN groups
The SP group was younger, had higher VAS scores, and had
a higher percentage of palm/sole swelling than the SN group.
However, they had less genital mucosal involvement and lower
platelet transfusion rates compared with the SN group.
A total of 45 Taiwanese patients (19 males and 26 females)
were enrolled in this study. All patients had type I DENV [8],
conﬁrmed by the Taiwan CDC. None of the patients had been
treated before the diagnosis of DF was made. The
demographic data, clinical symptoms, and disease outcome in
the SP and SN groups are shown in Table 1. The mean age
was (52.87 ± 16.24) years (range: 18–80 years of age), and the
SP group was signiﬁcantly younger than the SN group
(P = 0.001). All patients had fever as their initial symptom. The
interval between the onset of fever to the appearance of skin
eruption ranged from 1 to 7 d, with an average interval of 3.9 d.
Pruritus, swelling of the palms and soles, and mucosal
involvement were also noted.
The average VAS among the SP group (2.06) was signiﬁ-
cantly higher than that among the SN group (2.06 vs 0.28,occult blood test was positive or hematuria was revealed urinalysis.
Figure 1. Types of skin manifestations.
(A) maculopapular lesions (B) morbilliform lesions (C) petechial lesions and absence of a rash.
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patients in the SP group had swollen palms and soles than in the
SN group (40.63% vs 7.69%, respectively; P = 0.015). Further-
more, 58% of the DF patients had mucosal involvement, and thus
the incidence of genital mucosal involvement was signiﬁcantly
higher in the SN group (P = 0.008). In addition, the SN group also
had signiﬁcantly a higher rate of platelet transfusion (30.77% vs
3.16%, respectively; P = 0.003). However, there was no corre-
lation between age and platelet transfusion rate (P = 0.380).
Fever duration, hospitalization days, and disease courses
were similar between the SP and SN group. There was no dif-
ference in the duration of fever between the two patient groups
(4.52 ± 2.46 in the SP group vs 2.31 ± 1.90 in the SN group,
respectively; P = 0.177). In addition, the percentages of dengue
hemorrhagic fever in the SP group (4/32 patients) and the SN
group (2/13 patients) were not statistically different. There were
no differences in hospitalization days and disease course (from
the date of the onset of fever to the discharge day) between the
two groups.Table 2
Demographic data, clinical symptoms, type of lesions and outcome in DENV
Parameters Maculopapular
(n = 4)
Morb
macul
Age (year) 46.75 48.7
Males (n, %) 2 (50.00) 9 (4
Females (n, %) 2 (50.00) 12 (
Associated symptoms
Rash onset after fever (d) 4.75 3.86
Fever duration (d, mean ± SD) 4.00 ± 0.82 5.33
Itch (VAS = 1–10, mean ± SD) 2.25 ± 2.06 1.95
Palm/sole swelling (n, %) 3 (18.8) 10 (
Mucosa involvement
Oral 0 (0.00) 4 (1
Eye 0 (0.00) 1 (1
Genital 3 (16.7) 2 (1
Gastrointestinal 0 (0.00) 2 (9
Dengue hemorrhagic fever (n, %) 1 (25.00) 2 (1
Hemorrhagic manifestation (n, %)** 3 (75.00) 8 (3
Platelet transfusion (n, %) 0 (0.0) 0 (0
Hospitalization days (d, mean ± SD) 7.00 ± 1.15 6.43
Disease course (d, mean ± SD) 10.75 ± 2.06 9.90
*P < 0.05 was considered statistically signiﬁcant. **Stool occult blood test3.2. Types of skin manifestations
We categorized skin manifestations into 4 types: mac-
ulopapular, morbilliform, petechial, and absence of rash
(Figure 1). Of the 45 patients, 32 (71.12%) showed skin mani-
festations. The skin rash usually spared the face and presented
mainly on the limbs, although in some cases the trunk was the
predominant site. Patients with the maculopapular type rash
were the youngest among the 4 groups.
Patients in the morbilliform rash group had a higher per-
centage of swollen palms and soles (P = 0.035), less genital
mucosa involvement (P = 0.012), and the lowest platelet trans-
fusion rate (P = 0.038) of all 4 categories of skin manifestations.
To better investigate the inter-group differences, post-hoc anal-
ysis was used. There were no signiﬁcant differences in rash
onset after fever, fever duration, degree of pruritus, dengue
hemorrhagic fever presentation, hemorrhagic manifestations,
hospitalization days, and disease course between the two groups
(Table 2).infection patients.
illiforms
e (n = 21)
Petechia (n = 7) No skin rash
(n = 13)
P
6 48.57 63.69 0.036*
2.86) 3 (42.86) 5 (38.46) X
57.14) 4 (57.14) 8 (61.54) X
3.57 0 0.729
± 2.80 4.29 ± 1.98 2.31 ± 1.90 0.359
± 2.22 2.28 ± 2.75 0.38 ± 1.39 0.125
62.50) 2 (12.50) 1 (6.30) 0.035*
00.00) 0 (0.00) 0 (0.00) 0.17
00.00) 0 (0.00) 0 (0.00) 0.76
1.10) 4 (22.20) 9 (50.00) 0.012*
.52) 1 (14.29) 2 (15.38) 0.834
9.00) 1 (14.30) 2 (15.40) 0.852
8.10) 3 (42.86) 9 (69.23) 0.251
.00) 1 (14.29) 4 (30.77) 0.038*
± 2.91 6.86 ± 3.93 7.85 ± 3.87 0.686
± 2.83 9.57 ± 4.72 10.62 ± 3.20 0.861
was positive or hematuria was revealed on urinalysis.
Figure 2. Time-course laboratory data (mean ± SD) obtained from 45 patients with DENV infection.
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DENV infections
Figure 2 shows the time-course of laboratory data
(mean ± SD) obtained from the 45 patients with DENV infec-
tion. We deﬁned the date of fever onset as the ﬁrst day the
disease was detected. The mean leukocyte count and mean
platelet count reached their nadirs ﬁrst on the fourth to eighth
day of the illness, followed by the mean alanine aminotrans-
ferase (ALT) level, which peaked on the twelfth day, as theFigure 3. Time-course laboratory ﬁndings of SP group and SN group.mean hemoglobin (Hb)-hematocrit (Hct) level reached the nadir.
The mean leukocyte and platelet counts returned to normal
levels within 12 d, whereas it took 3 weeks for the mean ALT
level to return to normal values.
3.4. Low Hb and Hct dynamic levels in the SN group
Figure 3 shows the time-course laboratory differences be-
tween the SP group and the SN group. The average Hb level in
the SN group was statistically lower than in the SP group
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Hct level in the SN group was statistically lower than that in the
SP group (25.5% vs 37.05%, respectively; P = 0.030). In
addition, the SN group had lower mean platelet counts (60500/
mL) compared with the SP group (66000/mL), even though there
was no signiﬁcant difference statistically (P = 0.130). The mean
leukocyte and platelet counts reached normal values earlier in
the SN group patients than in the SP group.
4. Discussion
This is the ﬁrst study to investigate the clinical signiﬁcance
of skin rash in DF patients. The pruritic sensation with swollen
palms and soles were more common in the SP group than in
the SN group. It is interesting to note that more hemorrhagic
manifestations, especially genital mucosal involvement, and
higher incidence of platelet transfusion, were found in the SN
group. Although the SN group was older, we found that
platelet transfusion rate had signiﬁcant correlation with skin
rash rather than age. The percentage of dengue hemorrhagic
fever in the 4 groups did not differ signiﬁcantly. Patients with
morbilliform rash had a higher incidence of palm/sole swelling
and a lower platelet transfusion rate than did patients with the
other types of rash. In addition, we found that the mean
leukocyte count and mean platelet count reached their nadirs
on the fourth to eighth day of the illness, while the mean Hb
and Hct levels took about 2 weeks to reach their lowest levels.
It took 2–3 weeks for the abnormal laboratory data to be
normal. After analyzing the time-course laboratory data, we
found that the SN group had lower Hb and Hct levels than did
the SP group.
Wu et al. reported that skin dendritic cells are likely the
initial target of DENV infection in arthropod-borne transmission
of virus to humans [9]. These authors demonstrated a novel
model for the initial events in arboviral infection. They
theorized that damaged small blood vessels give rise to the
skin rash noted in DF patients, but there was debate over
whether the vessel damage was due to a direct destructive
effect of the virus or to another cause [10]. The pathogenesis
of skin rash was thought to be caused by the interaction
between the virus and host cells, which subsequently led to
release of different type of chemical mediators and initiation
of the immunological mechanisms [11].
The characteristic exanthem of DF is estimated to occur in
50–82% of patients [9,12]. The initial rash involves a ﬂushing
erythema of the face, neck, and chest that typically occurs
within the ﬁrst 24–48 h of the onset of symptoms and is
thought to be the result of capillary dilatation. The subsequent
rash, seen 3–5 d later, is characterized by a generalized
morbilliform eruption with petechiae and islands of sparing
(‘white islands in a sea of red’), and is thought to be an
immune response to the virus [9,13]. Some patients display
only the initial rash and recover completely; others develop
the more generalized eruption. In our study, 70% of patients
showed skin rash, the morbilliform rash was the predominant
type.
It is estimated that mucosal involvement occurs in 15%–30%
of patients with DENV [11]. Azfai et al. [6] and Mahboob et al.
[13] reported that the oral mucosa is the most common target,
while Thomas et al. [12] revealed that conjunctival congestion
is usually the ﬁrst symptom of the disease. In our study, only1 patient had conjunctival involvement, while 4 patients had
oral mucosal involvement. However, almost half of our
patients presented with genital mucosal involvement, such as
hematuria and vaginal bleeding.
In previous studies, only dermatologic manifestations in
DENV-infected patients were reported. Besides, the skin rash
was often asymptomatic [9]. Edema of the ankle, leg, and face
has also been reported in other studies [13]. In our experience,
pruritus may be the most uncomfortable symptom, and in this
study swollen palms/soles were often noted. However, this is
also the ﬁrst study to evaluate the difference between clinical
presentations and disease outcome in patients with or without
skin rash.
We also obtained time-course laboratory data for all 45
patients with DENV infections. Itoda et al. [14] reported that
the mean leukocyte count and mean platelet count reached
the nadir on the sixth and eighth days of illness, respectively,
and then returned to normal levels within 10 days. We noted
a similar pattern in our patients. In addition, mean Hct, Hb,
and ALT levels slowly returned to normal within 3 weeks
after the disease onset. Chen et al. [15] reported that
thrombocytopenia may be a useful indicator of severity of
dengue infection. In our study, patients in the SN group had
more severe thrombocytopenia than did patients in the SP
group, even though the difference was not statistically
signiﬁcant (P = 0.130). These clinicians should pay more
attention to platelet counts in DF patients who do not have a
skin rash.
Our results also showed that among DENV patients, mor-
billiform macules may lead to skin pruritus and swelling of
palms or soles, and the disease course and complications were
not worse than in patients without skin rash. For patients with
skin rash, the pathologic reports revealed superﬁcial perivascular
edema, mononuclear inﬁltration, and endothelial swelling of
small blood vessels [16,17]. In a study in Thailand, de Andino
et al. reported that only 6 of 53 patients with DHF had
dengue virus antigen, IgM, and complements in the upper
dermal plexus shown by immunoﬂuorescence [16]. Thus, the
skin rash may represent a reaction of vessels to cytokines
rather than to widespread viral infection. We hypothesized that
the skin rash in such patients may be the expression of
inﬂammatory cell inﬁltration and dermal edema after increased
permeability of vessels. The presence of a skin rash suggests
the susceptibility of vessels to the cytokines that were
produced by an intact immune system. Except for increased
itching scores and swelling of palms or soles, there was
neither a prolonged disease course nor poor prognosis in the
DF patients with skin rash.
Our study had several limitations. First, the number of cases
was small. Second, all the cases were collected from the emer-
gency department of our hospital. These patients had relatively
more severe and complicated viral infections than would be seen
in local clinics. Third, we only followed our patients for about 3
weeks. The long-term outcome between SP and SN groups
should be further investigated.
Dengue fever poses a huge burden to any healthcare system.
It has a wide clinical spectrum ranging from self-limiting disease
to severe fatal illness. The presence of skin rash aids in early
diagnosis of dengue fever. Although patients with dengue fever
and skin rash have itching and swollen palms and soles, the
disease course and complications are not worse than among
patients who do not have skin rash.
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